Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Aripiprazole Added on Methylphenidate in the Treatment of Youths With Comorbid ADHD and DMDD

NCT03358277 is registered in ClinicalTrials.gov with Tri-Service General Hospital (TSGH) as lead sponsor.

NCT NCT03358277
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03358277 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Aripiprazole Added on Methylphenidate in the Treatment of Youths With Comorbid ADHD and DMDD
Lead sponsor
Tri-Service General Hospital (TSGH)
Phase
Not applicable
Overall status
Completed
Start date
November 19, 2014
Completion date
August 12, 2017
Enrollment
58 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

disruptive mood dysregulation disorder